Question 6

Dutasteride is indicated to treat symptoms associated with benign prostatic hyperplasia.

Dutasteride is primarily used to manage symptoms related to benign prostatic hyperplasia (BPH), which is an enlargement of the prostate gland that can lead to urinary difficulties.

A) generalized-onset seizures.

This option is incorrect as generalized-onset seizures are neurological events that are not treated with dutasteride. Instead, they are typically managed with anticonvulsant medications specific to seizure disorders.

B) Parkinson's disease.

Parkinson's disease is a progressive neurological disorder characterized by motor symptoms such as tremors and rigidity. Dutasteride does not address the symptoms of this condition, making this option incorrect.

C) benign prostatic hyperplasia.

This option is correct. Dutasteride is specifically indicated for the treatment of benign prostatic hyperplasia, as it helps to reduce the size of the prostate and alleviate urinary symptoms associated with this condition.

D) rheumatoid arthritis.

Rheumatoid arthritis is an autoimmune condition affecting joints. Dutasteride does not have any effects on this disease, as it does not address inflammation or immune response, rendering this option incorrect.

Conclusion

Dutasteride is definitively indicated for the treatment of benign prostatic hyperplasia, which is fundamental for patients experiencing related urinary symptoms. The other options fail to relate to the therapeutic uses of dutasteride, highlighting its specific application in managing prostate enlargement.